Concord Biotech IPO vs TVS Supply Chain Solutions IPO

Comparision between Concord Biotech IPO and TVS Supply Chain Solutions IPO.

IPO Details

Concord Biotech IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while TVS Supply Chain Solutions IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Concord Biotech IPO	TVS Supply Chain Solutions IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Kotak Mahindra Capital Company Limited Citigroup Global Markets India Private Limited Jefferies India Private Limited	Jm Financial Limited Axis Capital Limited J.P. Morgan India Private Limited Bnp Paribas Equirus Capital Private Limited Nuvama Wealth Management Limited
Registrar	Link Intime India Private Ltd	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Concord Biotech IPO is up to ₹1,551.00 Cr whereas the issue size of the TVS Supply Chain Solutions IPO is up to ₹880.00 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of TVS Supply Chain Solutions IPO is ₹197.00 per share.

	Concord Biotech IPO	TVS Supply Chain Solutions IPO
Face Value	₹1 per share	₹1 per share
Issue Price (Lower)	₹705.00 per share	₹187.00 per share
Issue Price (Upper)	₹741.00 per share	₹197.00 per share
Issue Price (Final)	₹741.00 per share	₹197.00 per share
Discount (Retail)
Discount (Employee)	₹70.00 per share
Market Lot Size	20 shares	76 shares
Fresh Issue Size		3,04,56,853 shares
Fresh Issue Size (Amount)		up to ₹600.00 Cr
OFS Issue Size	2,09,25,652 shares	1,42,13,198 shares
OFS Issue Size (Amount)	up to ₹1,551.00 Cr	up to ₹280.00 Cr
Issue Size Total	2,09,25,652 shares	4,46,70,051 shares
Issue Size Total (Amount)	up to ₹1,551.00 Cr	up to ₹880.00 Cr

IPO Timetable

Concord Biotech IPO opens on Aug 04, 2023, while TVS Supply Chain Solutions IPO opens on Aug 10, 2023. The closing date of Concord Biotech IPO and TVS Supply Chain Solutions IPO is Aug 08, 2023, and Aug 14, 2023, respectively.

	Concord Biotech IPO	TVS Supply Chain Solutions IPO
Anchor Bid Date	Aug 03, 2023	Aug 09, 2023
Issue Open	Aug 04, 2023	Aug 10, 2023
Issue Close	Aug 08, 2023	Aug 14, 2023
Basis Of Allotment (Tentative)	Aug 11, 2023	Aug 18, 2023
Initiation of Refunds (Tentative)	Aug 14, 2023	Aug 21, 2023
Credit of Share (Tentative)	Aug 17, 2023	Aug 22, 2023
Listing date (Tentative)	Aug 18, 2023	Aug 23, 2023
Anchor Lockin End date 1	Sep 10, 2023	Sep 17, 2023
Anchor Lockin End date 2	Nov 09, 2023	Nov 16, 2023

Financials

Concord Biotech IPO P/E ratio is 32.29, as compared to TVS Supply Chain Solutions IPO P/E ratio of 189.42.

Concord Biotech IPO

TVS Supply Chain Solutions IPO

Financial

Concord Biotech IPO Financial Information (Restated Consolidated)
Period Ended	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	1,182.55	1,312.80	1,513.98
Revenue	630.75	736.35	888.48
Profit After Tax	234.89	174.93	240.08
Net Worth	999.37	1,103.22	1,290.00
Reserves and Surplus
Total Borrowing	86.35	60.59	31.24

Amount in ₹ Crore

TVS Supply Chain Solutions IPO Financial Information (Restated Consolidated)
Period Ended	31 Mar 2020	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	5,462.92	4,990.06	5,789.73	6,210.92
Revenue	6,792.76	6,999.69	9,299.94	10,311.01
Profit After Tax	-248.00	-76.34	-45.80	41.76
Net Worth	510.80	490.69	714.00	723.55
Reserves and Surplus	493.35	473.94	713.76	774.19
Total Borrowing	2,160.12	1,547.92	1,763.78	1,989.62

Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

44.08%

46.65%

Promoter Shareholding (Post-Issue)

44.08%

41.6%

P/E Ratio

32.29

189.42

Market Cap

₹7752.06 Cr.

₹8746.00 Cr.

ROE

20.06%%

5.50%%

ROCE

24.27%%

7.64%%

Debt/Equity

EPS

₹20.79

₹1.04

RoNW

20%%

5.50%%

Shares Offered

In the Concord Biotech IPO retail investors (RII) are offered 73,20,479 shares while in TVS Supply Chain Solutions IPO retail investors are offered 73,20,479 shares. Qualified institutional buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 1,34,01,016 shares in TVS Supply Chain Solutions IPO.

	Concord Biotech IPO	TVS Supply Chain Solutions IPO
Anchor Investor Reserveration	62,74,695 shares	2,01,01,522 shares
Market Maker Reserveration
QIB	41,83,130 shares	1,34,01,016 shares
NII	31,37,348 shares	67,00,507 shares
RII	73,20,479 shares	44,67,005 shares
Employee	10,000 shares	0 shares
Others
Total	1,46,50,957 shares	2,45,68,529 shares

Bids Received (Subscription)

Concord Biotech IPO subscribed 24.87x in total, whereas TVS Supply Chain Solutions IPO subscribed 2.85x.

	Concord Biotech IPO	TVS Supply Chain Solutions IPO
QIB (times)	67.67x	1.37x
NII (times)	16.99x	2.44x
Big NII (times)	19.30x	2.39x
Small NII (times)	12.37x	2.55x
RII (times)	3.78x	7.89x
Employee (times)	24.48x
Other (times)
Total (times)	24.87x	2.85x

Compare with others

Concord Biotech IPO	TVS Supply Chain Solutions IPO
Aeroflex Industries IPO	Vishnu Prakash R Punglia IPO
Pyramid Technoplast IPO	Aeroflex Industries IPO
India Shelter Finance IPO	Pyramid Technoplast IPO
Balaji Speciality Chemicals IPO	India Shelter Finance IPO
TVS Supply Chain Solutions IPO	Balaji Speciality Chemicals IPO
SBFC Finance IPO	Concord Biotech IPO
Yatharth Hospital IPO	SBFC Finance IPO
Netweb Technologies India IPO	Yatharth Hospital IPO
Utkarsh Small Finance Bank IPO	Netweb Technologies India IPO
Senco Gold IPO	Utkarsh Small Finance Bank IPO

Comments

Add a public comment...